Lotus Ebitda vs Net Income From Continuing Ops Analysis

600186 Stock

5.30 0.05 0.95%

Lotus Health financial indicator trend analysis is infinitely more than just investigating Lotus Health Group recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lotus Health Group is a good investment. Please check the relationship between Lotus Health Ebitda and its Net Income From Continuing Ops accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lotus Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ebitda vs Net Income From Continuing Ops

Ebitda vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lotus Health Group Ebitda account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong relationship.

The correlation between Lotus Health's Ebitda and Net Income From Continuing Ops is 0.63. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Lotus Health Group, assuming nothing else is changed. The correlation between historical values of Lotus Health's Ebitda and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Lotus Health Group are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Ebitda i.e., Lotus Health's Ebitda and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

0.63

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Ebitda

Net Income From Continuing Ops

Most indicators from Lotus Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lotus Health Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lotus Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 145.4 M. The current year's Tax Provision is expected to grow to about 42.1 M

	2021	2022	2023	2024 (projected)
Gross Profit	223.4M	238.6M	360.2M	233.3M
Research Development	22.1M	21.6M	28.7M	15.4M

Gross Profit Research Development

Lotus Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Other Liab	Net Tangible Assets	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Deferred Long Term Liab	Short Long Term Debt	Non Current Liabilities Other
Total Assets		0.18	-0.13	0.63	0.59	0.07	0.0	-0.76	0.44	0.7	0.61	0.28	0.03	-0.47	-0.25	0.72	-0.03	-0.04	0.67	0.01	0.44	-0.33	-0.23	-0.43	0.23	0.04
Other Current Liab	0.18		0.77	-0.48	-0.03	-0.6	-0.84	-0.53	-0.23	0.72	0.48	0.58	0.75	0.27	-0.56	0.61	-0.36	-0.79	0.74	-0.72	0.79	-0.04	-0.1	-0.78	0.63	0.71
Total Current Liabilities	-0.13	0.77		-0.81	-0.33	-0.74	-0.7	-0.08	-0.46	0.34	0.3	0.36	0.94	0.47	-0.51	0.28	-0.32	-0.73	0.42	-0.6	0.54	0.24	0.23	-0.52	0.45	0.57
Total Stockholder Equity	0.63	-0.48	-0.81		0.37	0.74	0.61	-0.3	0.38	0.06	0.12	-0.28	-0.76	-0.64	0.44	0.15	0.03	0.64	-0.02	0.6	-0.25	-0.38	-0.29	0.23	-0.28	-0.47
Retained Earnings	0.59	-0.03	-0.33	0.37		-0.2	-0.13	-0.54	0.95	0.49	0.15	0.62	-0.02	-0.2	-0.55	0.42	0.66	-0.23	0.48	-0.28	0.43	-0.11	-0.24	-0.43	0.29	0.16
Accounts Payable	0.07	-0.6	-0.74	0.74	-0.2		0.7	0.13	-0.08	-0.38	-0.18	-0.63	-0.87	-0.49	0.81	-0.24	-0.16	0.77	-0.42	0.78	-0.62	-0.33	-0.26	0.56	-0.46	-0.44
Cash	0.0	-0.84	-0.7	0.61	-0.13	0.7		0.4	0.03	-0.64	-0.46	-0.71	-0.75	-0.36	0.71	-0.58	0.08	0.92	-0.64	0.95	-0.86	-0.09	0.1	0.81	-0.55	-0.73
Other Assets	-0.76	-0.53	-0.08	-0.3	-0.54	0.13	0.4		-0.42	-0.94	-0.64	-0.55	-0.23	0.43	0.49	-0.85	0.09	0.46	-0.78	0.38	-0.59	0.24	0.29	0.62	-0.55	-0.45
Long Term Debt	0.44	-0.23	-0.46	0.38	0.95	-0.08	0.03	-0.42		0.32	-0.04	0.52	-0.14	-0.25	-0.43	0.23	0.78	-0.14	0.26	-0.13	0.2	-0.09	-0.09	-0.2	0.17	0.13
Net Receivables	0.7	0.72	0.34	0.06	0.49	-0.38	-0.64	-0.94	0.32		0.71	0.68	0.48	-0.19	-0.65	0.89	-0.11	-0.66	0.88	-0.6	0.8	-0.19	-0.19	-0.78	0.59	0.56
Inventory	0.61	0.48	0.3	0.12	0.15	-0.18	-0.46	-0.64	-0.04	0.71		0.19	0.32	-0.42	-0.38	0.86	-0.47	-0.34	0.66	-0.42	0.55	-0.29	-0.18	-0.5	0.41	0.17
Other Current Assets	0.28	0.58	0.36	-0.28	0.62	-0.63	-0.71	-0.55	0.52	0.68	0.19		0.58	0.36	-0.79	0.44	0.5	-0.8	0.69	-0.73	0.76	0.03	-0.09	-0.76	0.6	0.7
Total Liab	0.03	0.75	0.94	-0.76	-0.02	-0.87	-0.75	-0.23	-0.14	0.48	0.32	0.58		0.43	-0.73	0.38	-0.06	-0.84	0.55	-0.71	0.66	0.23	0.24	-0.63	0.54	0.65
Intangible Assets	-0.47	0.27	0.47	-0.64	-0.2	-0.49	-0.36	0.43	-0.25	-0.19	-0.42	0.36	0.43		-0.2	-0.42	0.27	-0.3	-0.04	-0.36	0.25	0.28	0.09	-0.2	-0.05	0.2
Common Stock	-0.25	-0.56	-0.51	0.44	-0.55	0.81	0.71	0.49	-0.43	-0.65	-0.38	-0.79	-0.73	-0.2		-0.54	-0.29	0.79	-0.68	0.85	-0.73	-0.09	0.12	0.7	-0.57	-0.59
Property Plant Equipment	0.72	0.61	0.28	0.15	0.42	-0.24	-0.58	-0.85	0.23	0.89	0.86	0.44	0.38	-0.42	-0.54		-0.28	-0.54	0.84	-0.53	0.76	-0.21	-0.3	-0.75	0.52	0.47
Other Liab	-0.03	-0.36	-0.32	0.03	0.66	-0.16	0.08	0.09	0.78	-0.11	-0.47	0.5	-0.06	0.27	-0.29	-0.28		-0.1	-0.07	-0.07	0.01	0.09	0.1	0.0	-0.01	0.1
Net Tangible Assets	-0.04	-0.79	-0.73	0.64	-0.23	0.77	0.92	0.46	-0.14	-0.66	-0.34	-0.8	-0.84	-0.3	0.79	-0.54	-0.1		-0.63	0.87	-0.78	-0.17	-0.09	0.77	-0.66	-0.86
Long Term Investments	0.67	0.74	0.42	-0.02	0.48	-0.42	-0.64	-0.78	0.26	0.88	0.66	0.69	0.55	-0.04	-0.68	0.84	-0.07	-0.63		-0.61	0.85	-0.33	-0.33	-0.84	0.71	0.57
Total Current Assets	0.01	-0.72	-0.6	0.6	-0.28	0.78	0.95	0.38	-0.13	-0.6	-0.42	-0.73	-0.71	-0.36	0.85	-0.53	-0.07	0.87	-0.61		-0.81	-0.09	0.15	0.75	-0.51	-0.62
Non Current Assets Total	0.44	0.79	0.54	-0.25	0.43	-0.62	-0.86	-0.59	0.2	0.8	0.55	0.76	0.66	0.25	-0.73	0.76	0.01	-0.78	0.85	-0.81		-0.02	-0.22	-0.94	0.49	0.63
Non Currrent Assets Other	-0.33	-0.04	0.24	-0.38	-0.11	-0.33	-0.09	0.24	-0.09	-0.19	-0.29	0.03	0.23	0.28	-0.09	-0.21	0.09	-0.17	-0.33	-0.09	-0.02		0.09	-0.13	-0.17	0.08
Non Current Liabilities Total	-0.23	-0.1	0.23	-0.29	-0.24	-0.26	0.1	0.29	-0.09	-0.19	-0.18	-0.09	0.24	0.09	0.12	-0.3	0.1	-0.09	-0.33	0.15	-0.22	0.09		0.38	-0.12	-0.09
Deferred Long Term Liab	-0.43	-0.78	-0.52	0.23	-0.43	0.56	0.81	0.62	-0.2	-0.78	-0.5	-0.76	-0.63	-0.2	0.7	-0.75	0.0	0.77	-0.84	0.75	-0.94	-0.13	0.38		-0.61	-0.69
Short Long Term Debt	0.23	0.63	0.45	-0.28	0.29	-0.46	-0.55	-0.55	0.17	0.59	0.41	0.6	0.54	-0.05	-0.57	0.52	-0.01	-0.66	0.71	-0.51	0.49	-0.17	-0.12	-0.61		0.58
Non Current Liabilities Other	0.04	0.71	0.57	-0.47	0.16	-0.44	-0.73	-0.45	0.13	0.56	0.17	0.7	0.65	0.2	-0.59	0.47	0.1	-0.86	0.57	-0.62	0.63	0.08	-0.09	-0.69	0.58

Click cells to compare fundamentals

Lotus Health Account Relationship Matchups

Lotus Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.2B	1.5B	2.3B	2.4B	2.4B	2.4B
Other Current Liab	348.2M	285.2M	224.8M	9.0M	6.6M	6.2M
Total Current Liabilities	2.0B	1.3B	1.1B	1.2B	1.1B	1.5B
Total Stockholder Equity	310.9M	385.3M	1.4B	1.4B	1.5B	903.9M
Retained Earnings	(1.6B)	(1.5B)	(1.5B)	(1.5B)	(1.4B)	(1.3B)
Accounts Payable	351.6M	588.4M	775.7M	908.5M	681.1M	407.0M
Cash	1.2B	470.6M	1.2B	1.4B	1.3B	1.3B
Other Assets	397.2M	344.2M	317.7M	332.3M	382.1M	401.2M
Net Receivables	135.6M	111.4M	105.5M	102.9M	103.5M	98.3M
Inventory	79.0M	118.8M	92.5M	74.2M	139.1M	170.4M
Other Current Assets	127.8M	128.5M	106.7M	51.0M	59.5M	56.6M
Total Liab	2.1B	1.4B	1.1B	1.3B	1.1B	1.6B
Intangible Assets	144.5M	140.7M	136.9M	124.3M	120.7M	198.6M
Property Plant Equipment	251.8M	108.5M	202.6M	267.3M	240.6M	228.6M
Other Liab	25.7M	21.8M	19.6M	19.3M	17.3M	16.2M
Net Tangible Assets	(745.2M)	166.4M	244.6M	1.3B	1.5B	1.5B
Total Current Assets	1.6B	842.8M	1.5B	1.7B	1.6B	1.2B
Non Current Assets Total	597.3M	661.0M	745.5M	720.0M	806.1M	736.7M
Non Currrent Assets Other	62.8M	597.3M	24.7M	24.3M	41.8M	39.8M
Non Current Liabilities Total	45.8M	19.6M	19.6M	20.5M	42.2M	24.7M
Non Current Liabilities Other	24.9M	21.4M	19.3M	18.5M	6.2M	5.9M
Net Invested Capital	334.9M	736.0M	1.4B	1.4B	1.6B	854.6M
Net Working Capital	(477.9M)	(490.5M)	444.2M	478.1M	564.4M	592.7M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Lotus Stock

Balance Sheet is a snapshot of the financial position of Lotus Health Group at a specified time, usually calculated after every quarter, six months, or one year. Lotus Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lotus Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lotus currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lotus Ebitda vs Net Income From Continuing Ops Analysis

Ebitda vs Net Income From Continuing Ops

Ebitda vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Ebitda

Net Income From Continuing Ops

Lotus Health fundamental ratios Correlations

Lotus Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lotus Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Lotus Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 0.95	Retained Earnings
Total Current Assets	+ 0.95	Cash
Total Liab	+ 0.94	Total Current Liabilities
Net Tangible Assets	+ 0.92	Cash
Property Plant Equipment	+ 0.89	Net Receivables
Long Term Investments	+ 0.88	Net Receivables

Deferred Long Term Liab	- 0.94	Non Current Assets Total
Net Receivables	- 0.94	Other Assets
Total Liab	- 0.87	Accounts Payable
Non Current Liabilities Other	- 0.86	Net Tangible Assets
Non Current Assets Total	- 0.86	Cash
Property Plant Equipment	- 0.85	Other Assets